BSE Circulars (21849)
Bombay Stock Exchange circulars covering trading rules, listing requirements, compliance guidelines, market operations, and regulatory changes for market participants.
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BSE/ICCL announces the settlement calendar for the Offer to Buy – Acquisition Window (Buyback) for Jagsonpal Pharmaceuticals Limited, with … | |||||||||||||||
BSE/ICCL announces the settlement calendar for the Offer to Buy – Acquisition Window (Buyback) for Jagsonpal Pharmaceuticals Limited, with bidding open from May 8 to May 14, 2026 and settlement on May 21, 2026.
| |||||||||||||||
BSE/ICCL announces the settlement calendar for the Offer to Buy Acquisition Window (Delisting) for Piyush Limited, with bidding from May 12 … | |||||||||||||||
BSE/ICCL announces the settlement calendar for the Offer to Buy Acquisition Window (Delisting) for Piyush Limited, with bidding from May 12 to May 18, 2026 and settlement on May 27, 2026.
| |||||||||||||||
BSE notifies record date of 15 May 2026 for DEV LABTECH VENTURE LTD's sub-division of equity shares from Rs.10/- to Rs.5/- each and … | |||||||||||||||
BSE notifies record date of 15 May 2026 for DEV LABTECH VENTURE LTD's sub-division of equity shares from Rs.10/- to Rs.5/- each and simultaneous 1:1 bonus issue, resulting in market lot revision from 1000 to 4000.
| |||||||||||||||
BSE advises trading members to suspend dealing in commercial papers of 13 issuances across 7 companies ahead of their respective redemption … | |||||||||||||||
BSE advises trading members to suspend dealing in commercial papers of 13 issuances across 7 companies ahead of their respective redemption record dates between May 11–21, 2026.
| |||||||||||||||
BSE ICCL publishes the trading and settlement schedule for the Mutual Fund segment covering subscription (liquid and non-liquid) and … | |||||||||||||||
BSE ICCL publishes the trading and settlement schedule for the Mutual Fund segment covering subscription (liquid and non-liquid) and redemption transactions for the period 01.06.2026 to 30.06.2026.
| |||||||||||||||
BSE notifies members that Nippon India Quarterly Interval Fund – Series II will be available for transactions on the BSE StAR MF Platform … | |||||||||||||||
BSE notifies members that Nippon India Quarterly Interval Fund – Series II will be available for transactions on the BSE StAR MF Platform during the Specified Transaction Period from May 7–8, 2026.
| |||||||||||||||
BSE forwards SEBI circular on emerging advanced AI tools for vulnerability detection, directing all Regulated Entities to take note and … | |||||||||||||||
BSE forwards SEBI circular on emerging advanced AI tools for vulnerability detection, directing all Regulated Entities to take note and ensure compliance.
| |||||||||||||||
BSE imposes 100% margins under LT-ASM framework effective May 11, 2026, with securities moving to higher stages and some exiting the … | |||||||||||||||
BSE imposes 100% margins under LT-ASM framework effective May 11, 2026, with securities moving to higher stages and some exiting the framework effective May 7, 2026.
| |||||||||||||||
BSE notifies inclusion of securities under ST-ASM Stage I and Stage II with enhanced margin requirements of 50% and 100% respectively, … | |||||||||||||||
BSE notifies inclusion of securities under ST-ASM Stage I and Stage II with enhanced margin requirements of 50% and 100% respectively, effective May 08, 2026.
| |||||||||||||||
BSE forwards SEBI circular on emerging advanced AI tools for vulnerability detection, requiring all Regulated Entities to take note and … | |||||||||||||||
BSE forwards SEBI circular on emerging advanced AI tools for vulnerability detection, requiring all Regulated Entities to take note and ensure necessary compliance.
| |||||||||||||||